Also trades as: PPCBD (OTC) · $vol 0M
PPCB NASDAQ
Propanc Biopharma, Inc.
1W: -19.5%
1M: -50.7%
3M: -73.0%
YTD: -11.2%
1Y: -70.2%
3Y: -100.0%
5Y: -99.0%
$0.51
+0.01 (+1.30%)
Weekly Expected Move ±14.3%
$0
$0
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$23K
+0.0% ▲
Operating Income
-$18M
+68.3% ▲
Net Income
-$19M
+68.0% ▲
EPS (Diluted)
$-17.62
+95.3% ▲
EBITDA
-$18M
+68.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $18K | $22K | $0 | $23K |
| Gross Profit | -$6K | -$18K | -$22K | $0 | -$23K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $256K | $248K | $248K | $224K | $625K |
| SG&A Expenses | $2M | $2M | $1M | $57M | $18M |
| Operating Expenses | $2M | $2M | $2M | $57M | $18M |
| Operating Income | -$2M | -$2M | -$2M | -$57M | -$18M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $569K | $533K | $666K | $564K | $431K |
| Income Before Tax | -$3M | -$3M | -$2M | -$59M | -$19M |
| Tax Expense | -$55K | -$130K | -$129K | $0 | $0 |
| Net Income | -$3M | -$3M | -$2M | -$59M | -$19M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1119475.67 | $-31268.39 | $-1200.00 | $-14.85 | $-17.62 |
| EBITDA | -$2M | -$2M | -$1M | -$58M | -$18M |
| Shares Outstanding | 3 | 100 | 1417 | 4M | 1M |